Edwards Lifesciencesvs.Stryker
EW vs SYK · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Stryker is about 2.2× larger than Edwards Lifesciences by market cap; Stryker trades at the lower P/E (28.0 vs 47.4); year to date, Edwards Lifesciences leads (+0.6% vs −21.6%).
Side by side
| EW | SYK | |
|---|---|---|
| Market cap | $47.6B | $105B |
| Price | $84.24 | $276.97 |
| Today | −1.8% | +0.6% |
| Return YTD | +0.6% | −21.6% |
| Return 1Y | +11.8% | −25.4% |
| Since June 26, 2026 | −7.2% | −16.8% |
| P/E | 47.4 | 28.0 |
| P/S | 7.3 | 4.0 |
| P/B | 4.5 | 4.4 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Edwards LifesciencesEW
Heart valves, delivered by catheter as with TAVR or implanted surgically.
Full EW profile →StrykerSYK
Orthopaedic implants and surgical equipment, with Mako bringing robot assistance into the operating room.
Full SYK profile →More EW & SYK comparisons
Other head-to-heads in the Medtech & devices segment.
See where EW and SYK sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →